203 related articles for article (PubMed ID: 24798291)
1. Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.
Siqueira VL; Cardoso RF; Caleffi-Ferracioli KR; Scodro RB; Fernandez MA; Fiorini A; Ueda-Nakamura T; Dias-Filho BP; Nakamura CV
Antimicrob Agents Chemother; 2014 Jul; 58(7):3957-67. PubMed ID: 24798291
[TBL] [Abstract][Full Text] [Related]
2. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kaynar-Tascioglu J; Kaya B; Goktas P
Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
[TBL] [Abstract][Full Text] [Related]
3. Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.
Buyck JM; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2015 Jan; 59(1):258-68. PubMed ID: 25348528
[TBL] [Abstract][Full Text] [Related]
4. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.
Ermertcan S; Hoşgör M; Tünger O; Coşar G
Scand J Infect Dis; 2001; 33(11):818-21. PubMed ID: 11760161
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
6. The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.
Louie A; Grasso C; Bahniuk N; Van Scoy B; Brown DL; Kulawy R; Drusano GL
Antimicrob Agents Chemother; 2010 Jun; 54(6):2646-54. PubMed ID: 20368395
[TBL] [Abstract][Full Text] [Related]
7. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Pankuch GA; Lin G; Seifert H; Appelbaum PC
Antimicrob Agents Chemother; 2008 Jan; 52(1):333-6. PubMed ID: 17967915
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kucukercan M; Ceran N
Chemotherapy; 2003 Dec; 49(6):294-7. PubMed ID: 14671429
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
Srivastava P; Sivashanmugam K
Infect Genet Evol; 2021 Aug; 92():104824. PubMed ID: 33774177
[TBL] [
